Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy.
Intravenous heparin is routinely given after thrombolytic therapy for patients with acute myocardial infarction in the United States and in some, but by no means all, other countries. Several trials have documented improved infarct-artery patency in patients treated with heparin; however, none was l...
Hoofdauteurs: | Mahaffey, K, Granger, C, Collins, R, O'Connor, C, Ohman, E, Bleich, S, Col, J, Califf, R |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
1996
|
Gelijkaardige items
-
Low-molecular heparins in thrombolytic therapy of myocardial infarction patients
door: I. S. Yavelov
Gepubliceerd in: (2009-12-01) -
Intravenous thrombolytic therapy in myocardial infarction (review)
door: I I Staroverov
Gepubliceerd in: (2003-10-01) -
RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
door: Collins, R, et al.
Gepubliceerd in: (1987) -
RANDOMIZED FACTORIAL TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
door: Collins, R
Gepubliceerd in: (1987) -
HEPARIN IN THE PRESENCE OR ABSENCE OF ANTIPLATELET THERAPY - AN OVERVIEW OF RANDOMIZED TRIALS IN ACUTE MYOCARDIAL-INFARCTION
door: Macmahon, S, et al.
Gepubliceerd in: (1992)